Swiss All Share Index
16.669,46
PKT
+61,82
PKT
+0,37
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
27.09.11 | UBS outperform | RBC Capital Markets | |
27.09.11 | UBS hold | Société Générale Group S.A. (SG) | |
26.09.11 | Novartis buy | Vontobel Research | |
26.09.11 | UBS buy | Vontobel Research | |
26.09.11 | ARYZTA buy | Vontobel Research | |
23.09.11 | Logitech buy | Vontobel Research | |
23.09.11 | Nestlé kaufen | Raiffeisen Centrobank AG | |
22.09.11 | Straumann hold | Société Générale Group S.A. (SG) | |
22.09.11 | ARYZTA buy | Vontobel Research | |
22.09.11 | Logitech buy | Vontobel Research | |
21.09.11 | SGS SA buy | Vontobel Research | |
20.09.11 | Zurich Insurance buy | ING | |
20.09.11 | Novartis buy | Vontobel Research | |
20.09.11 | UBS hold | Société Générale Group S.A. (SG) | |
20.09.11 | Holcim hold | Vontobel Research | |
19.09.11 | Temenos equal-weight | Morgan Stanley | |
19.09.11 | UBS buy | Vontobel Research | |
19.09.11 | Novartis buy | Vontobel Research | |
19.09.11 | Meyer Burger Technology kaufen | Die Actien-Börse | |
16.09.11 | UBS verkaufen | Independent Research GmbH | |
16.09.11 | Lonza hold | Vontobel Research | |
16.09.11 | UBS buy | Vontobel Research | |
15.09.11 | Kühne + Nagel International hold | ING | |
15.09.11 | Schindler buy | UniCredit Research | |
15.09.11 | Novartis neutral | Goldman Sachs Group Inc. | |
15.09.11 | Zurich Insurance hold | ING | |
15.09.11 | Kühne + Nagel International hold | Vontobel Research | |
15.09.11 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
15.09.11 | Lonza hold | Vontobel Research | |
14.09.11 | Temenos buy | UniCredit Research | |
14.09.11 | Novartis buy | Société Générale Group S.A. (SG) | |
14.09.11 | Sonova hold | Vontobel Research | |
14.09.11 | Novartis buy | Vontobel Research | |
14.09.11 | Lonza hold | Vontobel Research | |
12.09.11 | Swiss Re buy | Vontobel Research | |
12.09.11 | Swatch (I) buy | Vontobel Research | |
12.09.11 | Lonza hold | Vontobel Research | |
09.09.11 | Novartis outperform | Credit Suisse Group | |
09.09.11 | UBS overweight | Morgan Stanley | |
09.09.11 | Julius Bär equal-weight | Morgan Stanley |